Cochlear dysfunction as an early biomarker of cognitive decline in normal hearing and mild hearing loss
Abstract
INTRODUCTION: Age-related hearing loss is an important risk factor for cognitive decline. However, audiogram thresholds are not good estimators of dementia risk in subjects with normal hearing or mild hearing loss. Here we propose to use distortion product otoacoustic emissions (DPOAEs) as an objective and sensitive tool to estimate the risk of cognitive decline in older adults with normal hearing or mild hearing loss. METHODS: We assessed neuropsychological, brain magnetic resonance imaging, and auditory analyses on 94 subjects >Â 64 years of age. RESULTS: We found that cochlear dysfunction, measured by DPOAEsâand not by conventional audiometryâwas associated with Clinical Dementia Rating Sum of Boxes (CDR-SoB) classification and brain atrophy in the group with mild hearing loss (25 to 40Â dB) and normal hearing (<25Â dB). DISCUSSION: Our findings suggest that DPOAEs may be a non-invasive tool for detecting neurodegeneration and cognitive decline in the older adults, potentially allowing for early intervention.
Más información
| Título según WOS: | Cochlear dysfunction as an early biomarker of cognitive decline in normal hearing and mild hearing loss |
| Título según SCOPUS: | Cochlear dysfunction as an early biomarker of cognitive decline in normal hearing and mild hearing loss |
| Título de la Revista: | Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring |
| Volumen: | 16 |
| Número: | 1 |
| Editorial: | John Wiley and Sons Inc. |
| Fecha de publicación: | 2024 |
| Idioma: | English |
| DOI: |
10.1002/dad2.12467 |
| Notas: | ISI, SCOPUS |